Literature DB >> 24458511

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection.

Silvia Nozza1, Alba Bigoloni, Andrea Calcagno, Laura Galli, Angela Rosa Pignataro, Antonio D'Avolio, Alessia Carbone, Marco Ripa, Stefano Bonora, Adriano Lazzarin, Antonella Castagna.   

Abstract

Entities:  

Keywords:  multidrug resistance; raltegravir and maraviroc dosing; simplification

Mesh：

Substances：

Year:  2014        PMID： 24458511     DOI： 10.1093/jac/dkt530

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  2 in total

1.  Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent.

Authors:  Mariangela Cavarelli; Lara Mainetti; Angela Rosa Pignataro; Alba Bigoloni; Monica Tolazzi; Andrea Galli; Silvia Nozza; Antonella Castagna; Michela Sampaolo; Enzo Boeri; Gabriella Scarlatti
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

Review 2.  Maraviroc: a review of its use in HIV infection and beyond.

Authors:  Shawna M Woollard; Georgette D Kanmogne
Journal:  Drug Des Devel Ther       Date:  2015-10-01       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.